TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma

Abstract Background Recent studies indicated that T cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) and cluster of differentiation 47 (CD47) have emerged as new potential immunotherapy targets. However, the roles of TIGIT and CD47 in lung squamous cell carcinoma (LUSC) have not been...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yue Peng, Bin Qiu, Fengwei Tan, Jiachen Xu, Fenglong Bie, Huayu He, Lei Liu, He Tian, Guangyu Bai, Bolun Zhou, Yuan Li, Qilin Huai, Zhenlin Yang, Shugeng Gao
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2022-07-01
Serie:	Thoracic Cancer
Soggetti:	CD47 immunotherapy LUSC NSCLC TIGIT
Accesso online:	https://doi.org/10.1111/1759-7714.14478
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!